For labeling Tau, we used [125I]IPPI (Figure 3E), which selectively labeled and confirmed the presence of Tau in adjacent brain slices of all AD subjects, consistent with the immunostain in Figure 3C [31]. This evidence concerns the gene MAPT and Alzheimer disease.